These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19675369)

  • 1. What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?
    Brooks JT; Kaplan JE; Masur H
    Top HIV Med; 2009; 17(3):109-14. PubMed ID: 19675369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
    Mofenson LM; Brady MT; Danner SP; Dominguez KL; Hazra R; Handelsman E; Havens P; Nesheim S; Read JS; Serchuck L; Van Dyke R; ; ; ; ;
    MMWR Recomm Rep; 2009 Sep; 58(RR-11):1-166. PubMed ID: 19730409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.
    Kaplan JE; Benson C; Holmes KK; Brooks JT; Pau A; Masur H; ; ;
    MMWR Recomm Rep; 2009 Apr; 58(RR-4):1-207; quiz CE1-4. PubMed ID: 19357635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDC issues guidelines on treating OIs among adults. ART is cornerstone of treatment plan.
    AIDS Alert; 2005 Jun; 20(6):66-8. PubMed ID: 15962431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preface to the 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Service/Infectious Diseases Society of America.
    Clin Infect Dis; 1997 Oct; 25 Suppl 3():S299-312. PubMed ID: 9356831
    [No Abstract]   [Full Text] [Related]  

  • 6. Preaching what we practice: new guidelines for OI prophylaxis.
    Feinberg J
    AIDS Clin Care; 1999 Nov; 11(11):87-9, 94. PubMed ID: 11366709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current antiretroviral therapy and its impact on human immunodeficiency virus-related wasting.
    Sherer R
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):92-7. PubMed ID: 9625390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New OI prevention and treatment guidelines. Pediatric guidelines now are entirely separate.
    AIDS Alert; 2008 Sep; 23(9):100-1. PubMed ID: 18939303
    [No Abstract]   [Full Text] [Related]  

  • 9. Updated guidelines now available. Revised guidelines for using antiretroviral agents in adults and adolescents are now available on the Internet.
    AIDS Patient Care STDS; 2001 Jul; 15(7):400. PubMed ID: 11526901
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for fungal opportunistic infections prevention in persons infected with human immunodeficiency virus.
    Popa LG; Popa MI; Zaharia A; Ocneanu M
    Roum Arch Microbiol Immunol; 1999; 58(2):185-95. PubMed ID: 11845456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update: prophylaxis for HIV opportunistic infections.
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(1):5-6. PubMed ID: 11365025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
    Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
    Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.
    Benson CA; Kaplan JE; Masur H; Pau A; Holmes KK; ; ;
    MMWR Recomm Rep; 2004 Dec; 53(RR-15):1-112. PubMed ID: 15841069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic infections update.
    Proj Inf Perspect; 1999 Sep; (28):11-3. PubMed ID: 11367355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
    Masur H; Holmes KK; Kaplan JE
    Clin Infect Dis; 2000 Apr; 30 Suppl 1():S1-4. PubMed ID: 10770910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidiasis update.
    Proj Inf Perspect; 2000 Mar; (29):15-6. PubMed ID: 12772666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.
    Aberg JA; Kaplan JE; Libman H; Emmanuel P; Anderson JR; Stone VE; Oleske JM; Currier JS; Gallant JE;
    Clin Infect Dis; 2009 Sep; 49(5):651-81. PubMed ID: 19640227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated HIV treatment guidelines available.
    Tobias T
    AIDS Treat News; 1999 May; (No 319):3. PubMed ID: 11366462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunistic infections...is it safe to stop prophylaxis?
    Highleyman L
    BETA; 1999 Jan; 12(1):33-41. PubMed ID: 11367237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunistic infections in women with HIV AIDS.
    Lazenby GB
    Clin Obstet Gynecol; 2012 Dec; 55(4):927-37. PubMed ID: 23090461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.